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ABSTRACT
Evasion from apoptotic cell death is a character-
istic of cancer; genes that modulate this process
may be optimal for therapeutic attack. Identifying
key regulators of apoptosis is thus a central goal
in cancer therapy. Here, we describe a loss-of-
function screen that uses RNA interference libraries
to identify genes required for induction of apoptosis.
We used a short-hairpin RNA expressing vector
with high gene-expression silencing activity that
contained fetal brain cDNAs. Survived cells from
genotoxic stress were isolated to determine knock-
down of molecules that are crucial for induction
of apoptosis. We identified TBP-associated factor 1
(TAF1), a gene previously implicated as an essential
component of transcription machinery. Depletion
of TAF1 was associated with substantial atten-
uation of apoptosis induced by oxidative as well
as genotoxic stress. Microarray analysis further
demonstrated that a number of genes were tran-
scriptionally declined in cells silenced for TAF1.
Surprisingly, knocking down TAF1 exhibited a
marked decrease in p27
Kip1 expression, allowing
cells resistant from oxidative stress-induced apo-
ptosis. These results suggest that TAF1 regulates
apoptosis by controlling p27
Kip1 expression. Our
system provides a novel approach to identifying can-
didate genes that modulate apoptosis.
INTRODUCTION
Gene silencing by RNA interference (RNAi) has devel-
oped a powerful tool for loss-of-function studies (1).
Large-scale RNAi has facilitated the search for genes
required for diverse biological processes enabling stepwise
dissection of speciﬁc signaling pathways. Indeed, in com-
bination with high-throughput assays, genome-wide
RNAi studies have uncovered novel gene functions in
various biological processes (2). Several of these studies
were aimed at the identiﬁcation of genes essential for cell
division, cell cycle progression, endocytosis, tumor trans-
formation and apoptosis (3–10). Through these studies,
the power of this approach for the identiﬁcation of func-
tional modules has been demonstrated.
Regulation of apoptosis is critical in many fundamental
cellular processes. Because defective regulation of apopto-
sis provokes human disease, particularly cancers (11–13),
a global survey of genes essential for apoptosis in human
cells is thus not only advance the understanding of a fun-
damental biological process but also delivers novel diag-
nostic and therapeutic targets for cancer. In particular, the
signals that induce apoptosis in response to genotoxic
stress are largely unknown.
In this study, we used an improved short-hairpin
RNA (shRNA) library with genome-wide coverage (14).
We performed transfection of the shRNA library and
high-throughput cell-survival analysis to detect cells that
escaped from death, which were further analyzed by
TUNEL assays. We identiﬁed TBP-associated factor 1
(TAF1), an essential component of transcription machin-
ery. Microarray and apoptosis analyses demonstrated that
TAF1-mediated p27
Kip1 expression is involved in the
induction of apoptosis in response to genotoxic stress.
Using this approach, we uncovered a new gene implicated
in the apoptosis process, including transcriptional regula-
tory networks that govern cell death in mammalian cells.
MATERIALS AND METHODS
Cell culture
Human 293T embryonal kidney cells, HeLa cervical
cancer cells and MCF-7 breast cancer cells were cultured
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heat-inactivated fetal bovine serum, 100U/ml penicillin,
100U/ml streptomycin and 2mM L-glutamine. U2OS
osteosarcoma cells were cultured in RPMI 1640 medium
containing 10% heat-inactivated fetal bovine serum and
antibiotics.
Cell transfection
Plasmid DNA was transfected by using FuGENE 6 trans-
fection reagent (Roche, Basel, Switzerland). TAF1,
p27
Kip1 and caspase-3 gene-speciﬁc siRNAs were pur-
chased by Invitrogen, Carlsbad, CA, USA (Stealth
RNAi). Transfection of siRNAs was performed using
Lipofectamine RNAi MAX (Invitrogen).
Construction of shRNAexpression library
A shRNA library was constructed as previously described
(14). The library was generated from human fetal brain
cDNAs. DNA fragments in the library theoretically cover
a genome-wide transcriptome.
Construction of plasmids
TAF1 cDNA was ampliﬁed by PCR using the PfuUltra
TM
High-Fidelity DNA polymerase (Stratagene, La Jolla, CA,
USA) from pBlueBacHis250 and cloned into the pEGFP-
C1 vectors. p27
Kip1 cDNA was ampliﬁed by PCR from
293T cDNA and cloned into pcDNA3-Flag (15,16).
Measurement ofcell viability
Cells were cultured in 96-well plates and individually
transfected with shRNA expression vector. After treat-
ment with H2O2 or etoposide for 24h, MTS assays were
performed by adding 20ml CellTiter 96 AQueous One
Solution Reagent (Promega, Madison, WI, USA) directly
into 80ml culture media. After incubation for 3h at 378C
in a humidiﬁed 5% CO2 atmosphere, the absorbance was
measured at 490nm with the use of a multilabel counter
(PerkinElmer, Waltham, MA, USA).
RT–PCR analysis
Total RNA was isolated from cells using RNeasy kit
(Qiagen, Hilden, Germany). First strand cDNA synthesis
and following PCR were performed with 500ng of total
RNA using a SuperScript III One-Step RT–PCR System
with Platinum Taq DNA Polymerase (Invitrogen) accord-
ing to the manufacturer’s protocol. For TAF1 gene
expression, the nucleotide sequence of 50-GGTATGATA
TGCTGGGTGTC-30 was used as the sense primer, and
50-CAAGAGTGGCTGCAAAACCT-30 was used as the
antisense primer. For GAPDH gene expression, the
nucleotide sequence of 50-AAGGCTGTGGGCAAGGT
CATCCCT-30 was used as the sense primer, and 50-TTA
CTCCTTGGAGGCCATGTGGGC-30 was used as the
antisense primer. The reaction products were separated
on 2% agarose gels.
Immunoblot analysis
Immunoblot analysis was performed as described elsewhere
(17–19). Brieﬂy, cells were suspended with the lysis buﬀer
(50mM Tris–HCl, pH 7.6, 150mM NaCl, 1mM Na3VO4,
1mM PMSF, 1mM DTT, 10mg/ml aprotinin, 1mg/ml
leupeptin, 10mM NaF, 1mg/ml Pepstatin A, 0.05% deoxy-
cholic acid and 1% NP-40). Lysates were centrifuged at
15000g for 5min at 48C, and the supernatants were sepa-
ratedby SDS–PAGE and transferred to nitrocellulose mem-
branes. The membranes were incubated with anti-Flag
(Sigma-Aldrich, St. Louis, MO, USA), anti-TAF1 (Santa
Cruz Biotechnology, Santa Cruz, CA, USA), anti-p27
Kip1
(Santa Cruz Biotechnology), anti-Notch2 (Developmental
Studies Hybridoma Bank, Iowa City, IA, USA), antitubulin
(Sigma-Aldrich) or anti-PCNA (Santa Cruz Biotechnology).
Immune complexes were incubated with secondary anti-
bodies and visualized by chemiluminescence (PerkinElmer).
TUNEL assays
Cells cultured in poly-D-lysine-coated 4-well chamber
slides were transfected with plasmids or siRNAs and
then treated with H2O2 for 24h. Apoptotic cells were
detected byTUNEL assays usinga DeadEnd Fluorometric
TUNEL System (Promega). To detect apoptotic cells
expressing GFP-TAF1, the FluoroLink
TM Cy5-dUTP
(GE Healthcare, Buckinghamshire, England) was used
instead of Fluorescein-12-dUTP.
Microarray analysis
Total RNA was isolated from cells using an RNeasy kit
(Qiagen). Total RNA (5mg) was used to start the protocol
of One-Cycle cDNA Synthesis and to label cRNA, follow-
ing the manufacturer’s protocol (Aﬀymetrix, Santa Clara,
CA, USA). Before making a cocktail solution, 20mgo f
biotin-labeled cRNA was fragmented to 35–200 bases, and
15mg of cRNA fragment was used to prepare the cocktail
solution. The solution was applied into a GeneChip Human
Genome U133 plus 2.0 array (Aﬀymetrix) and hybridized
for 16h at 458C. After hybridization, the arrays were
washed and stained using Fluidic station 450 according to
protocol EukGE-WS2v5_450 and were then scanned using
the Aﬀymetrix GeneChip Scanner 3000. Analysis of the
data was performed as previously described (20).
Quantitative real-time RT–PCR analysis
Total RNA (5mg) was reverse transcribed into cDNA using
a Superscript III First-Strand Synthesis System for RT–
PCR (Invitrogen), following the manufacturer’s protocol.
For TAF1 gene expression, the nucleotide sequence of
50-CAACACAAACCAGTGACCAGAG-30 was used as
the sense primer, and 50-CCAGAATGCCTTAGCTTC
CA-30 was used as the antisense primer. For Notch2 gene
expression, the nucleotide sequence of 50-TCCTCTTCT
GCCTGCCTTTG-30 was used as the sense primer, and
50-TACCTTTCCCTTCCCCACCT-30 was used as the anti-
sense primer. For p27
Kip1 gene expression, the nucleotide
sequence of 50-TGGCATGTTTTGTGCATTTG-30 was
used as the sense primer, and 50-TTGGCTCAGTATGC
AACCTTTT-30 was used as the antisense primer. For
Actin gene expression, the nucleotide sequence of 50-GTG
GCCGAGGACTTTGATTG-30 was used as the sense
primer, and 50-TGGACTTGGGAGAGGACTGG-30 was
used as the antisense primer. The PCR reaction was
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Power SYBR Green Master Mix, 0.3mle a c ho f5 mM
primer, 5ml cDNA, 9.4ml water) using Power SYBR
Green PCR Master Mix (Applied Biosystems, Foster City,
CA, USA). The PCR program was as follows; after incuba-
tion for 10min at 958C, denaturation for 15s at 958C,
annealing for 60s at 608C and extension for 30s at 728C.
Cumulative ﬂuorescence was measured at the end of the
extension phase of each cycle. Quantiﬁcation was based
on standard curves from serial dilution of 293T total
RNA. The results were normalized for the level of actin.
RESULTS
shRNAscreen forregulators ofapoptosis in response
togenotoxic stress
In order to identify regulators of apoptosis by a genetic
screen, we have developed shRNAs that can theoretically
target a genome-wide trasncriptome (Figure 1A). The
shRNA expression library was constructed as described
elsewhere (14). Cells were transfected with the shRNA
library, then treated with H2O2 or etoposide for 24h.
Adherent cells, judged as survived, were harvested to
extract total cellular DNA (Figure 1B). The cassettes con-
taining promoter-hairpin-terminator were ampliﬁed by
PCR then ligated into the pUC19. After repeating this
cycle, selected shRNAs were individually transfected into
cells in 96-well plates, followed by treatment with H2O2 or
etoposide for 24h. Viability of cells was monitored by
MTS assays. We have evaluated >1000 shRNA clones
with respect to escape from cell death in response to geno-
toxic stress. When the absorbance obtained from cells
transfected with GFP vector was determined as a control,
75 clones, showing higher absorbance than control, were
selected in this screening step (Figure 1C). After sequenc-
ing the short-hairpin region, putative target genes for each
shRNA were determined by homology search. In this step,
30 clones were annotated as putative targets for at least
one gene (Table 1). To determine if each shRNAs are
capable for knock-down of target genes, cells were trans-
fected with each of the shRNAs in 96-well plates. Analysis
of mRNA expression by RT–PCR revealed that 8 of
the 30 clones were associated with substantial attenua-
tion of putative target genes. To further assess the eﬀects
on apoptosis by knock-down with shRNAs, cells were
transfected with each shRNA, followed by treatment
with H2O2 or etoposide for 24h. Apoptotic cells were
monitored by TUNEL assays. The results demonstrated
that transfection of cells with clone No. 20, which
targets TAF1 (Figure 2A), substantially attenuated
H2O2-induced apoptosis (Figure 2B). To conﬁrm these
results, we prepared siRNAs that target TAF1
(Figure 2A and Supplementary Figure 1A and B). 293T
cells were transfected with TAF1 siRNAs, followed
by treatment with H2O2. As a control, the eﬀect of trans-
fection with scramble siRNA or caspase-3 siRNA was
also evaluated. Knocking down TAF1 signiﬁcantly atten-
uated H2O2-induced apoptosis to a level similar to that
obtained with caspase-3 siRNA (Figure 2C and
Supplementary Figure 1C). Similar results were obtained
in HeLa, MCF-7 and U2OS cells (Supplementary
Figure 2). Comparable results were also obtained with
other stimuli, such as treatment with adriamycin
(Supplementary Figure 3). To establish whether TAF1
induces apoptosis in response to genotoxic stress, U2OS
cells were transfected with GFP vector or GFP-TAF1.
Upon exposure to H2O2, the ratio of apoptosis increased
in control cells (Figure 2D). More importantly, increased
apoptosis was signiﬁcantly augmented by ectopic expres-
sion of TAF1 (Figure 2D). These results collectively
demonstrated that TAF1 is a key regulator of apoptosis
in response to genotoxic stress.
TAF1 controls numerousgene expressions including
apoptosis- and cell cycle-associated genes
To explore potential molecular mechanisms by which
TAF1 regulates induction of apoptosis, we examined
TAF1-mediated transcriptional control by microarray
analysis. 293T cells were transfected with scramble
siRNA or TAF1 siRNA, then left untreated or treated
with H2O2 (Figure 3A). Total RNA was extracted and
mRNA expression was analyzed with a GeneChip
system. Knocking down TAF1 aﬀected a number of
gene expressions in both cells left untreated (1 versus 3;
629 genes) and those treated with H2O2 (2 versus 4;
542 genes) (Figure 3B). The number of merged genes
from both categories was 445 (Figure 3C). In contrast,
treatment with H2O2 had little if any eﬀect on gene expres-
sion, at least at the transcriptional level (1 versus 2;
35 genes, 3 versus 4; 32 genes). These results indicate
that TAF1 modulates a number of genes at the transcrip-
tional level, regardless of oxidative stress.
TAF1-mediated regulation of p27
Kip1 isassociated
with induction ofapoptosis
On the basis of the gene clusters obtained from expression
proﬁles (Figure 3B), we assessed genes categorized as
‘apoptosis’ and ‘cell cycle’ in terms of gene ontology. In
particular, we focused on p27
Kip1 and Notch2 since the
expressions of these genes were markedly reduced in
cells silenced for TAF1 (data not shown). To conﬁrm
the results of microarray analysis, gene expression was
explored by real-time RT–PCR. As shown for expression
proﬁles by microarray, knock-down of TAF1 in 293T
cells was associated with substantial attenuation of
Notch2 and p27
Kip1 (Figure 4A). With regard to p27
Kip1
expression, similar results were obtained in various
cells, such as MCF-7 and HeLa cells (Supplementary
Figure 4A). To further examine the expressions of these
genes at the protein level, TAF1-depleted 293T cells were
analyzed by immunoblotting. As expected, expression
levels of Notch2 and p27
Kip1 decreased in cells transfected
with TAF1 siRNA (Figure 4B), indicating that knock-
down of TAF1 attenuates both Notch2 and p27
Kip1
at the transcriptional and subsequent protein levels.
With regard to p27
Kip1 expression, similar ﬁndings were
obtained in MCF-7 and HeLa cells (Supplementary
Figure 4B). To determine if attenuation of Notch2 or
p27
Kip1 expression aﬀects the induction of apoptosis,
cells were transfected with scramble siRNA, Notch2
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Figure 1. shRNA library screen for pro-apoptotic genes. (A) Construction of shRNA expression library. The ptRNA-SS vector contains a tRNA
val
promoter and terminator in the pUC19 backbone, including ampicillin-resistance markers. The shRNA consists of a target transcript-speciﬁc 25–35
base double-stranded stem, connected by a 6-base loop sequence. (B) A schematic diagram of screening for identifying pro-apoptotic genes. 293T,
HeLa or MCF-7 cells transfected with shRNA expression libraries (8mg) were treated with H2O2 (200mM for 293T and HeLa cells, and 500mM for
MCF-7 cells) or etoposide (100mM for 293T cells, and 50mM for HeLa cells) for 24h. Adherent cells, judged as survived, were harvested, and total
genomic DNA were isolated. The promoter-shRNA-terminator region was ampliﬁed from total genomic DNA. PCR products were digested by SphI
and EcoRI, then ligated into pUC19. This process was repeated, and then the selected shRNAs were monoclonally expanded. Cells were plated on
96-well dishes and transfected with each of the shRNA clones, followed by treatment with H2O2 or etoposide for 24h. MTS assays were performed
to detect surviving cells. Sequencing of shRNA regions was carried out to identify putative target genes by homology search with BLAST. (C) MCF-
7 cells transfected with individual shRNA clones were treated with 250mMH 2O2 for 24h. MTS assays were performed to detect cells escaped from
apoptosis. Absorbance obtained from cells transfected with pEGFP-C1 vector was determined as a control (left panel; open bar). Cells showing
higher absorbance than the control value were selected as positive clones. A closed bar represents the value for untreated cells transfected with the
empty vector (left panel). Survival rates were deﬁned by calculating the absorbance obtained from the control cells with or without treatment, as 0 or
100%, respectively (right panel).
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Kip1 siRNA or caspase-3 siRNA, followed
by treatment with H2O2. Assessment of apoptosis by
TUNEL assays revealed that p27
Kip1-depleted cells were
substantially resistant to H2O2-induced cell death, similar
to caspase-3-depleted cells (Figure 4C). In contrast, there
was no signiﬁcant eﬀect on cells silenced for Notch2 (data
not shown), suggesting that p27
Kip1 is involved in apo-
ptosis induced by oxidative stress. To exclude the possi-
bility that the apoptotic eﬀect with p27
Kip1 is due to its
mRNA stability, 293T cells were transfected with scram-
ble siRNA or TAF1 siRNA then treated with transcrip-
tion inhibitor actinomycin D. Analysis of real-time
RT–PCR for p27
Kip1 expression revealed that knocking
down TAF1 is no eﬀect on decrease of p27
Kip1 mRNA
stability after the inhibition of transcription
(Supplementary Figure 5). These ﬁndings support the
involvement of p27
Kip1 expression on apoptosis induction
at the level of transcription rather than mRNA stability.
Interestingly, p27
Kip1 expression at the protein levels
slightly decreased after H2O2 stimulation (Figure 4B). In
this context, previous studies have shown that p27
Kip1
expression is down-regulated after H2O2 exposure whereas
the mechanism is uncertain (21). To deﬁne whether this is
controlled at the transcriptional level or the posttransla-
tional level, we have explored real-time RT–PCR analysis.
The results demonstrated that there is no signiﬁcant diﬀer-
ence on p27
Kip1 mRNA between the presence and the
absence of H2O2 (Supplementary Figure 6A; 1 versus 2
and 3 versus 4). This strongly suggests that the expression
level of p27
Kip1 mRNA remains unchanged even after
exposure to H2O2. Thus, the expression of p27
Kip1
should be controlled at the posttranslational level.
Table 1. Putative apoptosis-related genes identiﬁed by the RNAi screen
Cell line Reagent Clone no. Gene mRNA knockdown
HEK-293T H2O2 20 TAF1 RNA polymerase II, TATA box-binding protein (TBP)-associated
factor, 250kDa
+++
101 Ribosomal protein S27a +++
Etoposide 13 Procollagen C-endopeptidase enhancer 2  
32 McKusick-Kaufman syndrome –
82 Signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 –
115 Protein-L-isoaspartate (D-aspartate) O-methyltransferase –
149 TAR DNA-binding protein +++
HeLa S3 H2O2 8 N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase –
101 Reticulon 4 –
174 Metallothionein 1F (functional) –
Etoposide 21 Splicing factor, arginine/serine-rich 3 –
22 Vacuolar protein sorting 33 homolog A (Saccharomyces cerevisiae)–
Leukocyte-associated immunoglobulin-like receptor 2  
25 Pituitary tumor-transforming 1 interacting protein –
Surface glycoprotein ND
67 Calmodulin 2 (phosphorylase kinase, delta) –
72 Protein tyrosine phosphatase, nonreceptor type 11 (Noonan syndrome 1) ++
77 Solute carrier family 4, sodium bicarbonate transporter-like, member 10 ND
Eukaryotic translation elongation factor 1 alpha 1 –
101 Heat shock protein 90 –
102 Peroxiredoxin 1 –
108 Tumor necrosis factor (ligand) superfamily, member 14 –
171 DC31 –
MCF-7 H2O2 3 Aldehyde dehydrogenase 3 family, member B1 –
10 DnaJ (Hsp40) homolog, subfamily B, member 11 ++
22 Craniofacial development protein 1 +++
51 Solute carrier family 11 (proton-coupled divalent metal ion transporters),
member 1
++
54 Galactose-3-O-sulfotransferase 4 variant protein  
104 Autosomal highly conserved protein –
145 Histone deacetylase 2 –
Fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2,
Pfeiﬀer syndrome)
+++
PRP4 pre-mRNA processing factor 4 homolog (yeast) ND
Polyribonucleotide nucleotidyltransferase 1 ND
Caspase 6, apoptosis-related cysteine peptidase +
151 Mesoderm development candidate 2 ND
Cathepsin B +
Ring ﬁnger protein 125 +
Nicotinamide nucleotide adenylyltransferase 1 ND
POU domain transcription factor Oct-3 alternative transcript 6.3
(POU5F1) pseudogene mRNA
ND
185 Activated RNA polymerase II transcription cofactor 4 [SUB1
homolog (S. cerevisiae)]
 
199 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex,
4, 9kDa (NDUFA4), nuclear gene-encoding mitochondrial protein
–
5254 Nucleic Acids Research, 2008, Vol. 36, No. 16Indeed, it is well known that p27
Kip1 is degraded by the
ubiquitin–proteasome pathway (22,23). To determine this
is the case, 293T cells were pretreated with the proteasome
inhibitor MG-132 followed by treatment with H2O2.A s
shown previously, p27
Kip1 expression slightly decreased
upon exposure to H2O2. In contrast, pretreatment
with MG-132 abrogated oxidative stress-induced down-
regulation of p27
Kip1 (Supplementary Figure 6B).
Taken together, these results demonstrate that p27
Kip1
is partially degraded after H2O2 exposure by the
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Figure 2. Identiﬁcation of a target gene responsible for induction of apoptosis by genotoxic stress. (A) The identiﬁed shRNA (No. 20) suppresses
TAF1 gene. 293T cells were transfected with pEGFP-C1 vector or the shRNA clone No. 20. Total RNA was subjected to RT–PCR analysis using
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immunoblot analysis with anti-TAF1 or antitubulin. (B) TAF1 gene-speciﬁc shRNA or siRNA inhibits induction of apoptosis by genotoxic stress.
293T cells transfected with pUC19 vector or the shRNA clone No. 20 were left untreated (open bar) or treated (closed bar) with H2O2 for 24h. The
percentage of apoptotic cells was determined by TUNEL assays. The data represent the mean SD from three independent experiments, each
performed in triplicate. An asterisk indicates P<0.05. (C) 293T cells transfected with scramble siRNA, TAF1 siRNA or caspase-3 siRNA were left
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Nucleic Acids Research, 2008, Vol. 36, No. 16 5255ubiquitin–proteasome machinery. Importantly, knock-
ing down TAF1 signiﬁcantly attenuated p27
Kip1 expres-
sion at the transcriptional level (Figure 4A and
Supplementary Figure 6A). In this regard, it is conceivable
that substantial transcriptional suppression, but not
partial posttranslational suppression, of p27
Kip1 is neces-
sary for attenuation of apoptosis. To examine the synergic
eﬀect of TAF1 and p27
Kip1 on apoptosis, 293T cells were
transfected with TAF1 and p27
Kip1 siRNAs together fol-
lowed by H2O2 treatment. Analysis of TUNEL assays
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Kip1 expression. (A) Quantitation of TAF1, Notch2 and p27
Kip1
mRNAs by real-time RT–PCR analysis. Closed bars represent the value for the expression level of condition 3 (Figure 3A) divided by that of
condition 1; open bars represent the value for the expression level of condition 4 divided by that of condition 2. The value is normalized by the
expression level of actin. (B) 293T cells transfected with scramble siRNA or the TAF1 siRNA were left untreated or treated with H2O2 for 24h. Cell
lysates were subjected to immunoblot analysis with anti-TAF1, anti-Notch2, anti-p27
Kip1 or antitubulin. (C) p27
Kip1 gene-speciﬁc siRNA attenuates
induction of apoptosis in response to DNA damage. 293T cells transfected with scramble, p27
Kip1, or caspase-3 siRNA were left untreated (open bar)
or treated (closed bar) with H2O2 for 24h. The percentage of apoptotic cells was determined by TUNEL assays. The data indicate the means SD
from three independent experiments, each performed in triplicate. Two asterisks indicate P<0.01. Cell lysates were subjected to immunoblot analysis
with anti-p27
Kip1 or anti-PCNA. (D) 293T cells were transfected with scramble siRNA or the TAF1 and p27
Kip1 siRNAs together, then left untreated
or treated with H2O2 for 24h. Apoptotic cells were analyzed as described above. (E) 293T cells pretransfected with TAF1 siRNA were transfected
with Flag vector or Flag-p27
Kip1, then left untreated or treated with H2O2 for 24h. The percentage of apoptotic cells was determined by TUNEL
assays. The data indicate the means SD from three independent experiments, each performed in triplicate. One asterisk and two asterisks indicate
P<0.05 and P<0.01, respectively. Cell lysates were subjected to immunoblot analysis with anti-TAF1, anti-Flag or antitubulin.
Nucleic Acids Research, 2008, Vol. 36, No. 16 5257indicated that silencing of both TAF1 and p27
Kip1 confers
more pronounced eﬀect on attenuation of apoptosis as
compared to that of each knocking down alone
(Figure 4D). To further determine if induction of apoptosis
by TAF1 is mediated via p27
Kip1 expression, cells were
transfected with TAF1 siRNA, followed by forced expres-
sion of Flag vector or Flag-p27
Kip1. After stimulation of
cells with H2O2, we performed TUNEL assays to assess
apoptotic cell death. As shown previously, depletion of
TAF1 was associated with a marked attenuation of apo-
ptosis (Figure 4E). In contrast, forced expression of
p27
Kip1 in TAF1-depleted cells increased H2O2-induced
apoptosis (Figure 4E). These results demonstrated that
p27
Kip1 is, at least in part, responsible for TAF1-induced
cell death in response to genotoxic stress.
DISCUSSION
The cellular response to genotoxic stress that damages
DNA includes cell cycle arrest, activation of DNA
repair and in the event of irreparable damage, induction
of apoptosis. However, the signals that determine cell fate,
that is, survival or apoptosis, are largely unknown. In
order to identify genes required for apoptosis, we have
chosen a genome-scale RNAi screening strategy. The
emergence of RNAi as a mechanism to silence gene
expression has enabled loss-of-function analysis in mam-
malian cells in a potentially genome-wide manner (24–26).
We have utilized such an RNAi-based forward genetic
approach to identify genes that are involved in induction
of apoptosis in human cell lines. We identiﬁed TAF1 as a
candidate inducer of apoptosis. These ﬁndings support the
utility of this novel approach for the identiﬁcation of
genes relevant to apoptosis.
TAF1 is the largest subunit of TFIID, which is com-
posed of TBP and 13 TAFs (27,28). Binding of TFIID to
the core promoter elements is required for assembly of a
functional transcription initiation complex. TFIID also
serves as a coactivator by directly transmitting signals
from sequence-speciﬁc activators to other components of
the basal transcription machinery (29–31). Moreover,
TAFs function to directly activate selected genes in vivo
(32–34). TAF1 appears to function as a major scaﬀold by
which TBP and other TAFs interact in the assembly of
TFIID. TAF1 plays a critical role in the regulation of cell
growth (32). TAF1 possesses intrinsic protein kinase
activity (35), histone acetyltransferase activity (36) and
ubiquitin-activating and conjugating activity (37). The
TAF1 kinase is bipartite, consisting of N- and C-terminal
kinase domains. Previous work has demonstrated that
kinase activity of TAF1 is important for the progression
through the G1 phase (38). Another study has shown that
the retinoblastoma protein Rb interacts directly with
TAF1 and inhibits the kinase activity of TAF1 (39), sug-
gesting that the kinase activity of TAF1 may have a
pivotal role in tumor suppression. Whereas TAF1 aﬀects
cell cycle regulation, little is known about its eﬀect on
apoptosis control. To our knowledge, our study is the
ﬁrst to provide evidence suggesting that TAF1 functions
as an inducer of apoptosis in response to genotoxic stress.
The molecular mechanisms by which TAF1 exerts apop-
totic cell death are largely unclear. Further studies are
needed to clarify the precise roles for TAF1 exposed to
genotoxic stress. Nevertheless, our ﬁndings demonstrate
that transcriptional regulation of p27
Kip1 by TAF1 is, at
least in part, involved in induction of apoptosis. In this
regard, function as a transcription factor is apparently
required for TAF1-mediated induction of apoptosis.
The Cdk-inhibitor p27
Kip1 is ubiquitously expressed and
binds cyclin-Cdk2 to inhibit kinase activity (40). Human
cancers often express very low levels of p27
Kip1, which is
associated with poor prognosis. Recent studies implied
that p27
Kip1 is a tumor suppressor. Indeed, reduced
p27
Kip1 levels in primary cancers strongly correlate with
decreased patient survival (41). Germline mutations of
p27
Kip1 have also recently described in a subset of patients
with multiple endocrine neoplasia syndrome (42). Finally,
p27
Kip1-null mice develop organomegaly and pituitary
adenomas (43–45). The p27
Kip1 level is frequently con-
trolled by regulated translation and proteolysis (22,23).
However, little is known about the transcriptional control
of p27
Kip1. In this regard, the present study revealed that
TAF1 controls p27
Kip1 expression. Importantly, such con-
trol aﬀects induction of apoptosis in response to genotoxic
stress. Given that the down-regulation of p27
Kip1 mark-
edly impaired apoptosis, it is conceivable that low levels of
p27
Kip1 expression in cancer are associated with eﬃcient
escape from apoptosis induced by anticancer agents.
In conclusion, our ﬁndings provide evidence that phe-
notypic RNAi proﬁling can be useful for assigning poten-
tial functions to novel genes, in combination with
microarray analysis. This was highlighted by the identiﬁ-
cation of a putatively conserved transcriptional network
governing apoptosis in response to genotoxic stress.
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